Archives

by in
Entry Author Date Location
Clovis Oncology CEO Mahaffy Opens Up About Company’s Turbulent Year 10/17/13 Boulder/Denver
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Celgene, Sanofi, Stryker Execs Charged With Insider Trading 11/19/12 New York
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer 08/19/10 Boston
Page 1 of 1